OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Increased glucose metabolism in TAMs fuels O-GlcNAcylation of lysosomal Cathepsin B to promote cancer metastasis and chemoresistance
Qingzhu Shi, Qicong Shen, Yanfang Liu, et al.
Cancer Cell (2022) Vol. 40, Iss. 10, pp. 1207-1222.e10
Open Access | Times Cited: 185

Showing 1-25 of 185 citing articles:

Autophagy and cancer drug resistance in dialogue: Pre-clinical and clinical evidence
Yi Qin, Milad Ashrafizadeh, Vera Mongiardini, et al.
Cancer Letters (2023) Vol. 570, pp. 216307-216307
Closed Access | Times Cited: 150

Control of tumor-associated macrophage responses by nutrient acquisition and metabolism
Xian Zhang, Liangliang Ji, Ming O. Li
Immunity (2023) Vol. 56, Iss. 1, pp. 14-31
Open Access | Times Cited: 63

Glucose-driven histone lactylation promotes the immunosuppressive activity of monocyte-derived macrophages in glioblastoma
Alessandra De Leo, Alessio Ugolini, Xiaoqing Yu, et al.
Immunity (2024) Vol. 57, Iss. 5, pp. 1105-1123.e8
Closed Access | Times Cited: 54

OX40L-expressing M1-like macrophage exosomes for cancer immunotherapy
Yongkang Yu, Tingxuan Li, Meitong Ou, et al.
Journal of Controlled Release (2023) Vol. 365, pp. 469-479
Closed Access | Times Cited: 52

Targeting USP8 Inhibits O‐GlcNAcylation of SLC7A11 to Promote Ferroptosis of Hepatocellular Carcinoma via Stabilization of OGT
Jianing Tang, Guo Long, Kuan Hu, et al.
Advanced Science (2023) Vol. 10, Iss. 33
Open Access | Times Cited: 43

Mechanism insights and therapeutic intervention of tumor metastasis: latest developments and perspectives
Xiaoli Shi, Xinyi Wang, Wentao Yao, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 29

Metabolic regulation of the immune system in health and diseases: mechanisms and interventions
Tengyue Hu, Changhai Liu, Min Lei, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 21

The effects of metabolism on the immune microenvironment in colorectal cancer
Xingzhao Chen, Zhiyuan Ma, Zhiqiang Yi, et al.
Cell Death Discovery (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 19

Glucose metabolism of TAMs in tumor chemoresistance and metastasis
Juan Liu, Xuetao Cao
Trends in Cell Biology (2023) Vol. 33, Iss. 11, pp. 967-978
Closed Access | Times Cited: 38

SLC3A2 promotes tumor‐associated macrophage polarization through metabolic reprogramming in lung cancer
Zhuan Li, Songming Chen, Xiang He, et al.
Cancer Science (2023) Vol. 114, Iss. 6, pp. 2306-2317
Open Access | Times Cited: 36

On a sugar high: Role of O-GlcNAcylation in cancer
Giang Lê Minh, Emily M. Esquea, Riley G. Young, et al.
Journal of Biological Chemistry (2023) Vol. 299, Iss. 11, pp. 105344-105344
Open Access | Times Cited: 32

Highly Sensitive Imaging of Tumor Metastasis Based on the Targeting and Polarization of M2-like Macrophages
Pengcheng Yuan, Xiaodan Xu, Liangjun Zhu, et al.
Journal of the American Chemical Society (2023) Vol. 145, Iss. 14, pp. 7941-7951
Closed Access | Times Cited: 31

Advances in post-translational modifications of proteins and cancer immunotherapy
Yanqing Li, Runfang Zhang, Hu Hei
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 23

Abnormal glycosylation in glioma: related changes in biology, biomarkers and targeted therapy
Juan Yue, Roujie Huang, Zehao Lan, et al.
Biomarker Research (2023) Vol. 11, Iss. 1
Open Access | Times Cited: 22

Metabolic reprogramming and therapeutic resistance in primary and metastatic breast cancer
Shan Liu, Xingda Zhang, Wenzheng Wang, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 13

Extracellular vesicle-mediated ferroptosis, pyroptosis, and necroptosis: potential clinical applications in cancer therapy
Yi-Chi Yang, Qian Jiang, Ke-Ping Yang, et al.
Cell Death Discovery (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 12

Metabolic Signaling in Cancer Metastasis
Sarah Krieg, Sara Fernandes, Constantinos Kolliopoulos, et al.
Cancer Discovery (2024) Vol. 14, Iss. 6, pp. 934-952
Open Access | Times Cited: 12

Targeting O-GlcNAcylation in cancer therapeutic resistance: The sugar Saga continues
Lulu Chen, Mengxue Hu, Luojun Chen, et al.
Cancer Letters (2024) Vol. 588, pp. 216742-216742
Closed Access | Times Cited: 11

Targets of tumor microenvironment for potential drug development
Ling Zhang, Ziruoyu Wang, Kailu Liu, et al.
MedComm – Oncology (2024) Vol. 3, Iss. 1
Open Access | Times Cited: 10

The GFPT2-O-GlcNAcylation-YBX1 axis promotes IL-18 secretion to regulate the tumor immune microenvironment in pancreatic cancer
Huiru Zhang, Tianjiao Li, Xianjun Yu, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 4
Open Access | Times Cited: 8

Tumour organoids and assembloids: Patient‐derived cancer avatars for immunotherapy
Jie Mei, Xingjian Liu, Huixiang Tian, et al.
Clinical and Translational Medicine (2024) Vol. 14, Iss. 4
Open Access | Times Cited: 8

The complex interplay of tumor-infiltrating cells in driving therapeutic resistance pathways
Dengxiong Li, Fanglin Shao, Qingxin Yu, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 8

Page 1 - Next Page

Scroll to top